What is Brendan Bioscience?
Brendan Bioscience, LLC, founded in 2004, operates as an FDA-registered manufacturer specializing in Class 1 Analyte Specific Reagents. The company leverages an ISO 13485 certified GMP facility to produce a patented reagent component crucial for clinical researchers and CLIA-certified laboratories engaged in Delayed Food Sensitivity research and testing. Under the continued oversight of its founder, Brent Dorval, Ph.D., Brendan Bioscience maintains rigorous compliance with both ISO 13485 standards and FDA regulations, focusing on advancing immunoassay development within the medical diagnostics field.
How much funding has Brendan Bioscience raised?
Brendan Bioscience has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Brendan Bioscience?
The substantial large-scale late-stage funding indicates Brendan Bioscience is poised for significant expansion and further development of its specialized product offerings. This capital infusion is expected to bolster manufacturing capabilities, enhance research and development initiatives, and potentially broaden market reach for its patented reagents. The strategic investment signals strong confidence from backers in the company's trajectory and its role in advancing diagnostic testing.
See full Brendan Bioscience company page
